PSA density and clinical outcome in MRI-based active surveillance for prostate cancer: A joint longitudinal-survival analysis

被引：0
|
作者：
Stavrinides, V. [1 ]
Papageorgiou, G. [2 ]
Danks, D. [3 ]
Giganti, F. [1 ]
Pashayan, N. [4 ]
Trock, B. [5 ]
Freeman, A. [6 ]
Whitaker, H. [1 ]
Allen, C. [7 ]
Kirkham, A. [7 ]
Sonn, G. [8 ]
Punwani, S. [7 ]
Barratt, D. [9 ]
Emberton, M. [1 ]
Moore, C. [1 ]
机构：
[1] UCL, Dept Surg & Intervent Sci, London, England
[2] Birkbeck Coll, Dept Econ Math & Stat, London, England
[3] Univ Birmingham, Canc & Genom Sci, Birmingham, W Midlands, England
[4] UCL, Appl Hlth Res, London, England
[5] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA
[6] Univ Coll London Hosp NHS Fdn Trust, Dept Pathol, London, England
[7] Univ Coll London Hosp NHS Fdn Trust, Dept Radiol, London, England
[8] Stanford Univ, Dept Urol, Stanford, CA 94305 USA
[9] UCL, Dept Med Image Comp, London, England
来源：
EUROPEAN UROLOGY | 2021年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P1040
引用
收藏
页码：S1466 / S1467
页数：2
相关论文
共 50 条
  • [41] CHANGING THE PROSTATE CANCER DETECTION PARADIGM: CLINICAL APPLICATION OF MRI-BASED RISK STRATIFICATION IN MEN WITH SUSPECTED PROSTATE CANCER
    Tully, Karl
    Bahlburg, Henning
    Berg, Sebastian
    Hanske, Julian
    von Landenberg, Nicolas
    Noldus, Joachim
    Palisaar, Rein-Jueri
    Roghmann, Florian
    Brock, Marko
    JOURNAL OF UROLOGY, 2021, 206 : E76 - E76
  • [42] Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program
    Pål Møller
    Astrid Stormorken
    Christoffer Jonsrud
    Marit Muri Holmen
    Anne Irene Hagen
    Neal Clark
    Anita Vabø
    Ping Sun
    Steven A. Narod
    Lovise Mæhle
    Breast Cancer Research and Treatment, 2013, 139 : 155 - 161
  • [43] Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program
    Moller, Pal
    Stormorken, Astrid
    Jonsrud, Christoffer
    Holmen, Marit Muri
    Hagen, Anne Irene
    Clark, Neal
    Vabo, Anita
    Sun, Ping
    Narod, Steven A.
    Maehle, Lovise
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (01) : 155 - 161
  • [44] Is prostate specific antigen (PSA) density necessary in selecting prostate cancer patients for active surveillance and what should be the cutoff in the Asian population?
    Tsang, Chiu-Fung
    Lai, Terence C. T.
    Lam, Wayne
    Ho, Brian S. H.
    Ng, Ada T. L.
    Ma, Wai-Kit
    Yiu, Ming-Kwong
    Tsu, James H. L.
    PROSTATE INTERNATIONAL, 2019, 7 (02) : 73 - 77
  • [45] PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision making
    Venderbos, Lionne D. F.
    Roobol, Monique J.
    ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (02) : 219 - 224
  • [46] Using a Recurrent Neural Network To Inform the Use of Prostate-specific Antigen (PSA) and PSA Density for Dynamic Monitoring of the Risk of Prostate Cancer Progression on Active Surveillance
    Sushentsev, Nikita
    Abrego, Luis
    Colarieti, Anna
    Sanmugalingam, Nimalan
    Stanzione, Arnaldo
    Zawaideh, Jeries Paolo
    Caglic, Iztok
    Zaikin, Alexey
    Blyuss, Oleg
    Barrett, Tristan
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 52 : 36 - 39
  • [47] The reliability of digital rectal exam, PSA, repeat prostate biopsy, and endorectal MRI for following patients with clinically localized prostate cancer on active surveillance
    Miyamoto, Ryan K.
    Thompson, Ian M.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 154 - 154
  • [48] CORRELATION BETWEEN SINGLE-READER MRI-BASED PROSTATE VOLUME MEASUREMENTS AND SERUM PROSTATE-SPECIFIC ANTIGEN IN MEN WITH LOW-RISK PROSTATE CANCER ON ACTIVE SURVEILLANCE
    Feuer, Zachary S.
    Prabhu, Vinay
    Llukani, Elton
    Huang, Richard
    Rosenkrantz, Andrew
    Meng, Xiaosong
    Wysock, James S.
    Huang, William C.
    Taneja, Samir
    Lepor, Herbert
    JOURNAL OF UROLOGY, 2018, 199 (04): : E206 - E207
  • [49] Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL
    Lu, Yangbai
    Li, Binfei
    Huang, Hongxing
    Leng, Qu
    Wang, Qiang
    Zhong, Rui
    Huang, Yaqiang
    Li, Canyong
    Yuan, Runqiang
    Zhang, Yongxin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA≤10, and clinically localized prostate cancer
    Cheng, GC
    Chen, MH
    Whittington, R
    Malkowicz, SB
    Schnall, MD
    Tomaszewski, JE
    D'Amico, AV
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (01): : 64 - 70
12345